Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Epidemiology and genotype diversity of norovirus infections among children aged <5 years following rotavirus vaccine introduction in Blantyre, Malawi.

Hungerford D, Jere KC, Bar-Zeev N, Harris JP, Cunliffe NA, Iturriza-Gómara M.

J Clin Virol. 2020 Feb;123:104248. doi: 10.1016/j.jcv.2019.104248. Epub 2019 Dec 18.

2.

Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis.

Bennett A, Pollock L, Jere KC, Pitzer VE, Lopman B, Bar-Zeev N, Iturriza-Gomara M, Cunliffe NA.

J Infect Dis. 2019 Dec 13. pii: jiz612. doi: 10.1093/infdis/jiz612. [Epub ahead of print]

PMID:
31834930
3.

Prospective cohort study to investigate the burden and transmission of acute gastroenteritis in care homes: epidemiological results.

Inns T, Pulawska-Czub A, Harris JP, Vivancos R, Beeching NJ, Iturriza-Gomara M, O'Brien SJ.

BMJ Open. 2019 Dec 8;9(12):e033239. doi: 10.1136/bmjopen-2019-033239.

4.

Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England.

Hungerford DJ, French N, Iturriza-Gómara M, Read JM, Cunliffe NA, Vivancos R.

J Epidemiol Community Health. 2019 Nov;73(11):1020-1025. doi: 10.1136/jech-2019-213055. Epub 2019 Sep 11.

5.

Vaccine Effectiveness against DS-1-Like Rotavirus Strains in Infants with Acute Gastroenteritis, Malawi, 2013-2015.

Jere KC, Bar-Zeev N, Chande A, Bennett A, Pollock L, Sanchez-Lopez PF, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Iturriza-Gomara M, Cunliffe NA.

Emerg Infect Dis. 2019 Sep;25(9):1734-1737. doi: 10.3201/eid2509.190258.

6.

Family income and exposure to norovirus in childhood: Findings from the UK Millennium Cohort Study.

Violato M, Taylor-Robinson D, Hungerford D, Gray A, O'Brien S, Iturriza-Gomara M.

SSM Popul Health. 2019 Jul 3;8:100445. doi: 10.1016/j.ssmph.2019.100445. eCollection 2019 Aug.

7.

Molecular epidemiology of G12 rotavirus strains during eight consecutive epidemic seasons in the Basque Country (North of Spain), 2010-2018.

Arana A, Jere KC, Chaguza C, Montes M, Alkorta M, Iturriza-Gomara M, Cilla G.

Infect Genet Evol. 2019 Jul;71:67-75. doi: 10.1016/j.meegid.2019.03.016. Epub 2019 Mar 21.

PMID:
30905774
8.

Etiology of Diarrhea Among Hospitalized Children in Blantyre, Malawi, Following Rotavirus Vaccine Introduction: A Case-Control Study.

Iturriza-Gómara M, Jere KC, Hungerford D, Bar-Zeev N, Shioda K, Kanjerwa O, Houpt ER, Operario DJ, Wachepa R, Pollock L, Bennett A, Pitzer VE, Cunliffe NA.

J Infect Dis. 2019 Jun 19;220(2):213-218. doi: 10.1093/infdis/jiz084.

9.

Estimating Disability-Adjusted Life Years (DALYs) in Community Cases of Norovirus in England.

Harris JP, Iturriza-Gomara M, O'Brien SJ.

Viruses. 2019 Feb 21;11(2). pii: E184. doi: 10.3390/v11020184.

10.

Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to August 2016.

Hungerford D, Allen DJ, Nawaz S, Collins S, Ladhani S, Vivancos R, Iturriza-Gómara M.

Euro Surveill. 2019 Feb;24(6). doi: 10.2807/1560-7917.ES.2019.24.6.1700774.

11.

Infrequent Transmission of Monovalent Human Rotavirus Vaccine Virus to Household Contacts of Vaccinated Infants in Malawi.

Bennett A, Pollock L, Jere KC, Pitzer VE, Lopman B, Parashar U, Everett D, Heyderman RS, Bar-Zeev N, Cunliffe NA, Iturriza-Gomara M.

J Infect Dis. 2019 May 5;219(11):1730-1734. doi: 10.1093/infdis/jiz002.

12.

Norovirus strain types found within the second infectious intestinal diseases (IID2) study an analysis of norovirus circulating in the community.

Harris JP, Iturriza-Gomara M, Allen DJ, Kelly S, O'Brien SJ.

BMC Infect Dis. 2019 Jan 25;19(1):87. doi: 10.1186/s12879-019-3706-z.

13.

Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.

Pollock L, Bennett A, Jere KC, Dube Q, Mandolo J, Bar-Zeev N, Heyderman RS, Cunliffe NA, Iturriza-Gomara M.

Clin Infect Dis. 2019 Sep 27;69(8):1313-1319. doi: 10.1093/cid/ciy1067.

14.

Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK.

Hungerford D, Vivancos R, Read JM, Bonnett LJ, Bar-Zeev N, Iturriza-Gómara M, Cunliffe NA, French N.

Vaccine. 2018 Oct 29;36(45):6674-6682. doi: 10.1016/j.vaccine.2018.09.051. Epub 2018 Oct 4.

15.

Influence of Nonpolio Enteroviruses and the Bacterial Gut Microbiota on Oral Poliovirus Vaccine Response: A Study from South India.

Praharaj I, Parker EPK, Giri S, Allen DJ, Silas S, Revathi R, Kaliappan SP, John J, Prasad JH, Kampmann B, Iturriza-Gómara M, Grassly NC, Kang G.

J Infect Dis. 2019 Apr 8;219(8):1178-1186. doi: 10.1093/infdis/jiy568.

16.

Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.

Bennett A, Pollock L, Jere KC, Pitzer VE, Parashar U, Tate JE, Heyderman RS, Mwansambo C, French N, Nakagomi O, Iturriza-Gomara M, Everett D, Cunliffe NA, Bar-Zeev N; VacSurv Consortium.

Vaccine. 2018 Nov 12;36(47):7142-7148. doi: 10.1016/j.vaccine.2018.04.030. Epub 2018 Jun 7.

17.

How timely closure can reduce outbreak duration: gastroenteritis in care homes in North West England, 2012-2016.

Inns T, Keenan A, Huyton R, Harris J, Iturriza-Gomara M, O'Brien SJ, Vivancos R.

BMC Public Health. 2018 Apr 12;18(1):488. doi: 10.1186/s12889-018-5413-x.

18.

Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine.

Giri S, Kumar N, Dhanapal P, Venkatesan J, Kasirajan A, Iturriza-Gomara M, John J, Abraham AM, Grassly NC, Kang G.

J Infect Dis. 2018 Apr 11;217(9):1395-1398. doi: 10.1093/infdis/jix687.

19.

Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres.

Bennett A, Nagelkerke N, Heinsbroek E, Premkumar PS, Wnęk M, Kang G, French N, Cunliffe NA, Bar-Zeev N, Lopman B, Iturriza-Gomara M.

PLoS One. 2017 Dec 29;12(12):e0190256. doi: 10.1371/journal.pone.0190256. eCollection 2017.

20.

Causes of impaired oral vaccine efficacy in developing countries.

Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC.

Future Microbiol. 2018 Jan;13:97-118. doi: 10.2217/fmb-2017-0128. Epub 2017 Dec 8. Review.

21.

Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.

Parker EPK, Praharaj I, Zekavati A, Lazarus RP, Giri S, Operario DJ, Liu J, Houpt E, Iturriza-Gómara M, Kampmann B, John J, Kang G, Grassly NC.

Vaccine. 2018 Jan 4;36(2):264-272. doi: 10.1016/j.vaccine.2017.11.031. Epub 2017 Dec 6.

22.

Emergence of Double- and Triple-Gene Reassortant G1P[8] Rotaviruses Possessing a DS-1-Like Backbone after Rotavirus Vaccine Introduction in Malawi.

Jere KC, Chaguza C, Bar-Zeev N, Lowe J, Peno C, Kumwenda B, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Cunliffe NA, Iturriza-Gomara M.

J Virol. 2018 Jan 17;92(3). pii: e01246-17. doi: 10.1128/JVI.01246-17. Print 2018 Feb 1.

23.

Prospective cohort study to investigate the burden and transmission of acute gastroenteritis in care homes: a study protocol.

Inns T, Pulawska-Czub A, Harris JP, Vivancos R, Read JM, Beeching NJ, Allen DJ, Iturriza-Gomara M, O'Brien SJ.

BMJ Open. 2017 Nov 3;7(11):e018867. doi: 10.1136/bmjopen-2017-018867.

24.

Community-based surveillance of norovirus disease: a systematic review.

Inns T, Harris J, Vivancos R, Iturriza-Gomara M, O'Brien S.

BMC Infect Dis. 2017 Sep 29;17(1):657. doi: 10.1186/s12879-017-2758-1.

25.

Group A rotaviruses circulating prior to a national immunization programme in Nigeria: Clinical manifestations, high G12P[8] frequency, intra-genotypic divergence of VP4 and VP7.

Japhet MO, Famurewa O, Iturriza-Gomara M, Adesina OA, Opaleye OO, Niendorf S, Bock CT, Mas Marques A.

J Med Virol. 2018 Feb;90(2):239-249. doi: 10.1002/jmv.24949. Epub 2017 Sep 26.

PMID:
28906005
26.

Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.

Hungerford D, Smith K, Tucker A, Iturriza-Gómara M, Vivancos R, McLeonard C, A Cunliffe N, French N.

BMC Infect Dis. 2017 Aug 15;17(1):569. doi: 10.1186/s12879-017-2613-4.

27.

Whole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome reassortment events between human, bovine, caprine and porcine strains.

Bwogi J, Jere KC, Karamagi C, Byarugaba DK, Namuwulya P, Baliraine FN, Desselberger U, Iturriza-Gomara M.

PLoS One. 2017 Jun 22;12(6):e0178855. doi: 10.1371/journal.pone.0178855. eCollection 2017.

28.

Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study.

Sindhu KN, Cunliffe N, Peak M, Turner M, Darby A, Grassly N, Gordon M, Dube Q, Babji S, Praharaj I, Verghese V, Iturriza-Gómara M, Kang G.

BMJ Open. 2017 Mar 29;7(3):e016577. doi: 10.1136/bmjopen-2017-016577.

29.

Comparison of culture, single and multiplex real-time PCR for detection of Sabin poliovirus shedding in recently vaccinated Indian children.

Giri S, Rajan AK, Kumar N, Dhanapal P, Venkatesan J, Iturriza-Gomara M, Taniuchi M, John J, Abraham AM, Kang G.

J Med Virol. 2017 Aug;89(8):1485-1488. doi: 10.1002/jmv.24793. Epub 2017 Mar 6.

30.

Re-assessing the total burden of norovirus circulating in the United Kingdom population.

Harris JP, Iturriza-Gomara M, O'Brien SJ.

Vaccine. 2017 Feb 7;35(6):853-855. doi: 10.1016/j.vaccine.2017.01.009. Epub 2017 Jan 13.

31.

Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.

Mukhopadhya I, Murdoch H, Berry S, Hunt A, Iturriza-Gomara M, Smith-Palmer A, Cameron JC, Hold GL.

Vaccine. 2017 Jan 3;35(1):156-163. doi: 10.1016/j.vaccine.2016.11.028. Epub 2016 Nov 18.

PMID:
27876201
32.

The Gut Microbiome as Possible Key to Understanding and Improving Rotavirus Vaccine Performance in High-Disease Burden Settings.

Iturriza-Gómara M, Cunliffe NA.

J Infect Dis. 2017 Jan 1;215(1):8-10. doi: 10.1093/infdis/jiw521. Epub 2016 Oct 31. No abstract available.

PMID:
27803170
33.

Whole-genome characterisation of G12P[6] rotavirus strains possessing two distinct genotype constellations co-circulating in Blantyre, Malawi, 2008.

Nakagomi T, Do LP, Agbemabiese CA, Kaneko M, Gauchan P, Doan YH, Jere KC, Steele AD, Iturriza-Gomara M, Nakagomi O, Cunliffe NA.

Arch Virol. 2017 Jan;162(1):213-226. doi: 10.1007/s00705-016-3103-5. Epub 2016 Oct 7.

PMID:
27718073
34.

Foodborne viral infections.

Iturriza-Gomara M, O'Brien SJ.

Curr Opin Infect Dis. 2016 Oct;29(5):495-501. doi: 10.1097/QCO.0000000000000299. Review.

PMID:
27454403
35.

Emergence and spread of G3P[8] rotaviruses possessing an equine-like VP7 and a DS-1-like genetic backbone in the Basque Country (North of Spain), 2015.

Arana A, Montes M, Jere KC, Alkorta M, Iturriza-Gómara M, Cilla G.

Infect Genet Evol. 2016 Oct;44:137-144. doi: 10.1016/j.meegid.2016.06.048. Epub 2016 Jun 28.

PMID:
27370571
36.

Characterization of a Novel Conformational GII.4 Norovirus Epitope: Implications for Norovirus-Host Interactions.

Carmona-Vicente N, Vila-Vicent S, Allen D, Gozalbo-Rovira R, Iturriza-Gómara M, Buesa J, Rodríguez-Díaz J.

J Virol. 2016 Aug 12;90(17):7703-14. doi: 10.1128/JVI.01023-16. Print 2016 Sep 1.

37.

Norovirus Gastroenteritis in a Birth Cohort in Southern India.

Menon VK, George S, Sarkar R, Giri S, Samuel P, Vivek R, Saravanabavan A, Liakath FB, Ramani S, Iturriza-Gomara M, Gray JJ, Brown DW, Estes MK, Kang G.

PLoS One. 2016 Jun 10;11(6):e0157007. doi: 10.1371/journal.pone.0157007. eCollection 2016.

38.

Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells.

Carmona-Vicente N, Allen DJ, Rodríguez-Díaz J, Iturriza-Gómara M, Buesa J.

Virol J. 2016 May 21;13:82. doi: 10.1186/s12985-016-0538-y.

39.

The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants.

Grassly NC, Praharaj I, Babji S, Kaliappan SP, Giri S, Venugopal S, Parker EP, Abraham A, Muliyil J, Doss S, Raman U, Liu J, Peter JV, Paranjape M, Jeyapaul S, Balakumar S, Ravikumar J, Srinivasan R, Bahl S, Iturriza-Gómara M, Uhlig HH, Houpt ER, John J, Kang G.

Lancet Infect Dis. 2016 Aug;16(8):905-14. doi: 10.1016/S1473-3099(16)30023-8. Epub 2016 May 4.

40.

Early Detection of Epidemic GII-4 Norovirus Strains in UK and Malawi: Role of Surveillance of Sporadic Acute Gastroenteritis in Anticipating Global Epidemics.

Allen DJ, Trainor E, Callaghan A, O'Brien SJ, Cunliffe NA, Iturriza-Gómara M.

PLoS One. 2016 Apr 26;11(4):e0146972. doi: 10.1371/journal.pone.0146972. eCollection 2016.

41.

Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.

Bar-Zeev N, Jere KC, Bennett A, Pollock L, Tate JE, Nakagomi O, Iturriza-Gomara M, Costello A, Mwansambo C, Parashar UD, Heyderman RS, French N, Cunliffe NA; Vaccine Effectiveness and Disease Surveillance Programme, Malawi (VACSURV) Consortium.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S213-9. doi: 10.1093/cid/civ1183.

42.

Early impact of rotavirus vaccination in a large paediatric hospital in the UK.

Hungerford D, Read JM, Cooke RP, Vivancos R, Iturriza-Gómara M, Allen DJ, French N, Cunliffe N.

J Hosp Infect. 2016 Jun;93(2):117-20. doi: 10.1016/j.jhin.2015.12.010. Epub 2015 Dec 31.

PMID:
26876744
43.

In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13.

Hungerford D, Vivancos R; EuroRotaNet network members, Read JM, Pitzer VE, Cunliffe N, French N, Iturriza-Gómara M.

Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30106.

44.

Age-Specific Incidence Rates for Norovirus in the Community and Presenting to Primary Healthcare Facilities in the United Kingdom.

O'Brien SJ, Donaldson AL, Iturriza-Gomara M, Tam CC.

J Infect Dis. 2016 Feb 1;213 Suppl 1:S15-8. doi: 10.1093/infdis/jiv411.

45.

The epidemiology of rotavirus disease in under-five-year-old children hospitalized with acute diarrhea in central Uganda, 2012-2013.

Bwogi J, Malamba S, Kigozi B, Namuwulya P, Tushabe P, Kiguli S, Byarugaba DK, Desselberger U, Iturriza-Gomara M, Karamagi C.

Arch Virol. 2016 Apr;161(4):999-1003. doi: 10.1007/s00705-015-2742-2. Epub 2016 Jan 2.

46.

Diversity of human parechoviruses in Bulgaria, 2011: Detection of rare genotypes 8 and 10.

Mladenova Z, Dikova A, Thongprachum A, Petrov P, Pekova L, Komitova R, Iturriza-Gomara M, Ushijima H.

Infect Genet Evol. 2015 Dec;36:315-322. doi: 10.1016/j.meegid.2015.10.004. Epub 2015 Oct 9.

PMID:
26453770
47.

Diversity of group A rotavirus on a UK pig farm.

Chandler-Bostock R, Hancox LR, Payne H, Iturriza-Gomara M, Daly JM, Mellits KH.

Vet Microbiol. 2015 Nov 18;180(3-4):205-11. doi: 10.1016/j.vetmic.2015.09.009. Epub 2015 Sep 25.

48.

Detection of enterotoxigenic E. coli in hospitalised children with and without diarrhoea in Blantyre, Malawi.

Trainor E, Iturriza-Gómara M, Ngwira B, Cunliffe N.

Paediatr Int Child Health. 2016 May;36(2):102-5. doi: 10.1179/2046905515Y.0000000014.

PMID:
25940596
49.

Determination of a Viral Load Threshold To Distinguish Symptomatic versus Asymptomatic Rotavirus Infection in a High-Disease-Burden African Population.

Bennett A, Bar-Zeev N, Jere KC, Tate JE, Parashar UD, Nakagomi O, Heyderman RS, French N, Iturriza-Gomara M, Cunliffe NA.

J Clin Microbiol. 2015 Jun;53(6):1951-4. doi: 10.1128/JCM.00875-15. Epub 2015 Apr 8.

50.

Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.

Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, French N, Cunliffe NA; VacSurv Consortium.

Lancet Infect Dis. 2015 Apr;15(4):422-8. doi: 10.1016/S1473-3099(14)71060-6. Epub 2015 Jan 29.

Supplemental Content

Loading ...
Support Center